Officer Dennis Mulroy Files to Sell Another $1.15M in Stock, Continuing Recent Distribution
ANAB has more than doubled off its 52-week low of $11.402.
Summary
AnaptysBio officer Dennis Mulroy has filed to sell an additional $1.15 million in company stock, extending a recent trend of significant insider distribution despite the company's recent share repurchase announcement.
Key Events · Ownership and Investor Activity · ANAB
-
Officer Files to Sell $1.15M in Stock
Dennis Mulroy, an officer, filed a Form 144 to sell 22,491 shares of common stock, valued at approximately $1.15 million. The shares were acquired through a stock option exercise on the same day.
-
Continuation of Significant Insider Selling
This filing extends a pattern of substantial sales by Mulroy, who has sold 158,422 shares totaling over $8.8 million in gross proceeds over the past three months, as indicated in the filing's history.
-
Conflicting Signal with Share Repurchase Program
The ongoing insider selling occurs after AnaptysBio announced a new $100 million share repurchase program on May 12, 2026, creating a conflicting signal regarding management's view of the stock's value.
Analysis · ANAB · Life Sciences
Dennis Mulroy, an officer at AnaptysBio, has filed a Form 144 indicating intent to sell an additional $1.15 million worth of common stock. This follows a pattern of significant sales by Mulroy, totaling over $8.8 million in the past three months, and comes shortly after the company announced a $100 million share repurchase program. The consistent selling by a key officer, particularly after exercising options, suggests a lack of conviction at current price levels and contrasts with the company's stated intent to buy back shares.
At the time of this filing, ANAB was trading at $50.37 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $1.5B. The 52-week trading range was $11.40 to $72.36. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.